ClinicalTrials.gov
ClinicalTrials.gov Menu

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) (INSIGHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01513941
Recruitment Status : Completed
First Posted : January 20, 2012
Last Update Posted : May 5, 2016
Sponsor:
Information provided by (Responsible Party):
Janssen-Cilag International NV